Vanguard Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $187M | Sell |
|
|||||
|
2025
Q2 | $131M | Buy |
|
|||||
|
2025
Q1 | $114M | Buy |
|
|||||
|
2024
Q4 | $100M | Sell |
|
|||||
|
2024
Q3 | $97.3M | Buy |
|
|||||
|
2024
Q2 | $83.7M | Buy |
|
|||||
|
2024
Q1 | $55.6M | Sell |
|
|||||
|
2023
Q4 | $73.1M | Buy |
|
|||||
|
2023
Q3 | $53.5M | Buy |
|
|||||
|
2023
Q2 | $41.3M | Buy |
|
|||||
|
2023
Q1 | $30.6M | Buy |
|
|||||
|
2022
Q4 | $24.6M | Buy |
|
|||||
|
2022
Q3 | $26.2M | Buy |
|
|||||
|
2022
Q2 | $19.1M | Buy |
|
|||||
|
2022
Q1 | $16.9M | Sell |
|
|||||
|
2021
Q4 | $12.9M | Buy |
|
|||||
|
2021
Q3 | $14.6M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Sell |
|
|||||
|
2021
Q1 | $14.7M | Buy |
|
|||||
|
2020
Q4 | $11M | Buy |
|
|||||
|
2020
Q3 | $9.25M | Buy |
|
|||||
|
2020
Q2 | $9.21M | Buy |
|
|||||
|
2020
Q1 | $2.43M | Buy |
|
|||||
|
2019
Q4 | $1.97M | Sell |
|
|||||
|
2019
Q3 | $823K | Buy |
|